Amendment to Funding AgreementFunding Agreement • July 22nd, 2003 • Targeted Genetics Corp /Wa/ • Biological products, (no disgnostic substances)
This Amendment to the Funding Agreement (the “Funding Agreement”) dated August 8, 2003, between Targeted Genetics Corporation, a Washington corporation (“Targeted”), and Biogen, Inc., a Massachusetts corporation (“Biogen”) is made as of July 14, 2003 by and between Targeted and Biogen.
FIFTH AMENDMENT TO LEASE AGREEMENTLease Agreement • July 22nd, 2003 • Targeted Genetics Corp /Wa/ • Biological products, (no disgnostic substances)
This FIFTH AMENDMENT TO LEASE AGREEMENT (This “Amendment”) is entered into as of June 20, 2003 by and between Ironwood Apartments, Inc., as successor to Metropolitan Federal Savings and Loan Association (“Landlord”) and Targeted Genetics Corporation (“Tenant”).
AMENDMENT NO. 2 TO EXCLUSIVE SUBLICENSE AGREEMENTExclusive Sublicense Agreement • July 22nd, 2003 • Targeted Genetics Corp /Wa/ • Biological products, (no disgnostic substances)
THIS AMENDMENT NO.2 to the exclusive sublicense agreement (the “Amendment”) is made and entered into as of May 29, 2003 by and between Alkermes, Inc., a Pennsylvania corporation with its principal offices at 64 Sydney Street, Cambridge, MA 02139 (hereinafter referred to as “Alkermes”), and Targeted Genetics Corporation, a Washington corporation with its principal offices at 1100 Olive Way, Suite 100, Seattle, Washington 98101 (hereinafter referred to as “Targeted”).
